The Valley Desk

NCT02471183 · Interventional trial

Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension

Overall registry status Completed

Phase 3

Conditions Pulmonary Arterial Hypertension

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov